{"url":"https://lda.senate.gov/api/v1/filings/dd0f4f46-dcce-4e2e-87e7-fb9ecb0a5bca/","filing_uuid":"dd0f4f46-dcce-4e2e-87e7-fb9ecb0a5bca","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2024,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.senate.gov/filings/public/filing/dd0f4f46-dcce-4e2e-87e7-fb9ecb0a5bca/print/","filing_document_content_type":"text/html","income":"12000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Charles Dujon","dt_posted":"2024-10-03T18:25:31-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1401 Church St. NW","registrant_address_2":"#424","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20005","registrant":{"id":401106114,"url":"https://lda.senate.gov/api/v1/registrants/401106114/","house_registrant_id":45215,"name":"2359 STRATEGIES","description":"Provide strategic consulting services.","address_1":"1401 Church St. NW","address_2":"#424","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20005","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"CHARLES DUJON","contact_telephone":"+1 202-297-7594","dt_updated":"2025-02-19T14:03:37.162297-05:00"},"client":{"id":212318,"url":"https://lda.senate.gov/api/v1/clients/212318/","client_id":12,"name":"TRAVERE THERAPEUTICS","general_description":"Biopharmaceutical company","client_government_entity":false,"client_self_select":null,"state":"CA","state_display":"California","country":"US","country_display":"United States of America","ppb_state":"CA","ppb_state_display":"California","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2021-08-19"},"lobbying_activities":[{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Rare kidney disease","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":110845,"prefix":null,"prefix_display":null,"first_name":"CHARLES","nickname":null,"middle_name":null,"last_name":"DUJON","suffix":null,"suffix_display":null},"covered_position":"Legislative Director (1998-2013), Rep. Jesse Jackson, Jr.","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Rare kidney disease","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":110845,"prefix":null,"prefix_display":null,"first_name":"CHARLES","nickname":null,"middle_name":null,"last_name":"DUJON","suffix":null,"suffix_display":null},"covered_position":"Legislative Director, U.S. House of Representatives","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MED","general_issue_code_display":"Medical/Disease Research/Clinical Labs","description":"Rare kidney disease","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":110845,"prefix":null,"prefix_display":null,"first_name":"CHARLES","nickname":null,"middle_name":null,"last_name":"DUJON","suffix":null,"suffix_display":null},"covered_position":"Legislative Director (1998-2013), Rep. Jesse Jackson, Jr.","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"Orphan Drug Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":110845,"prefix":null,"prefix_display":null,"first_name":"CHARLES","nickname":null,"middle_name":null,"last_name":"DUJON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"Orphan drug act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":110845,"prefix":null,"prefix_display":null,"first_name":"CHARLES","nickname":null,"middle_name":null,"last_name":"DUJON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}